[
  {
    "ts": "2026-02-01T07:38:48+00:00",
    "headline": "Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy",
    "summary": "​Abbott Laboratories (NYSE:ABT) is one of the Best 52-Week Low Stocks to Invest In. On January 29, Freedom Capital upgraded the stock from Hold to Buy, but lowered the price target from $130 to $120. Earlier, on January 23, UBS reiterated a Buy rating on the stock with a $158 price target. ​The positive ratings […]",
    "url": "https://finance.yahoo.com/news/freedom-capital-upgrades-abbott-laboratories-073848175.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "13c28a1a-b0ca-3558-b0d7-9d3d66c30b54",
      "content": {
        "id": "13c28a1a-b0ca-3558-b0d7-9d3d66c30b54",
        "contentType": "STORY",
        "title": "Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy",
        "description": "",
        "summary": "​Abbott Laboratories (NYSE:ABT) is one of the Best 52-Week Low Stocks to Invest In. On January 29, Freedom Capital upgraded the stock from Hold to Buy, but lowered the price target from $130 to $120. Earlier, on January 23, UBS reiterated a Buy rating on the stock with a $158 price target. ​The positive ratings […]",
        "pubDate": "2026-02-01T07:38:48Z",
        "displayTime": "2026-02-01T07:38:48Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/8b4f8f18dabae8e04006be71641b541a",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0.cPFvd9TvfcjdQCwca9Lw--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/8b4f8f18dabae8e04006be71641b541a.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0csMLTsQPdOhgav4WMAy9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/8b4f8f18dabae8e04006be71641b541a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/freedom-capital-upgrades-abbott-laboratories-073848175.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/freedom-capital-upgrades-abbott-laboratories-073848175.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]